Masimo Corp (NASDAQ:MASI)
| 138.66 Delayed Data As of Jun 24 |  +3.03 / +2.23%Today’s Change | 112.07 Today|||52-Week Range 305.21 | -52.64% Year-to-Date |
Latest MASI News | Press Releases
Today’s Trading
| Previous close | 135.63 |
| Today’s open | 136.18 |
| Day’s range | 135.78 - 139.12 |
| Volume | 10,126 |
| Average volume (3 months) | 1,087,326 |
| Market cap | $6.9B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -5.24% |
| Earnings growth (this year) | +16.04% |
| Earnings growth (next 5 years) | +1.30% |
| Revenue growth (last year) | +8.34% |
| P/E ratio | 35.8 |
| Price/Sales | 13.63 |
| Price/Book | 4.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVCRNovocure Ltd | +5.03 | +7.12% |
| TNDMTandem Diabetes Care... | +2.78 | +4.73% |
| LIVNLivaNova PLC | +2.10 | +3.37% |
| IRTCiRhythm Technologies... | +5.34 | +4.86% |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | July 26, 2022 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $229.6M |
| Net profit margin | 18.53% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
